Navigation Links
ARIUS announces fourth quarter and year-end fiscal 2007 financial results
Date:1/29/2008

p>- Preparing to perform preclinical toxicology studies in 2008 in

preparation for filing a Phase I IND application.

CD9 Cancer Stem Cell Program

- CD9 is more highly expressed in leukemia stems cells than normal

stem cells.

- Presented positive findings demonstrating the ability of the lead

anti-CD9 antibody to kill cancer stem cells in an in vivo model using

cells from human leukemia patients.

- Demonstrated ability to kill cancer stem cells while potentially

leaving normal cells alone.

CD63 Antibody Program

- Licensed to Genentech, Inc. in March 2006, the CD63 program continues

to advance in preclinical studies in a variety of cancer indications

as part of a program to move the lead antibody towards the clinic.

Takeda Collaboration

- Discovered and delivered novel antibodies to Takeda under the terms

of the research collaboration agreement, ARIUS has successfully met

its obligations to date and has received all scheduled research

payments from Takeda.

Additional Product Updates

- Currently, ARIUS has antibody programs targeting the MCSP antigen and

37LRP, in addition to several other undisclosed programs.

- Furthered lead optimization for antibodies covering additional novel

targets generated using ARIUS' proprietary FunctionFIRST(TM)

technology.

Other Highlights:

- Granted eight US patents for antibodies and one European patent to

date, and currently have 18 issued or allowed patents covering its

antibody programs and discovery platform and over 185 patents pending

worldwide.

- Promoted Susan Hahn, PhD to the position of Vice President of

Development.

- Appointed Mr. James Rae and Mr. Joseph Zakrzewski to its Board of

Directors and also appointed Mr. Carl Gordon a
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
2. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
3. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
4. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
5. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
6. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
7. ARIUS to present at Chinese Global Financial Forum
8. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
9. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
10. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
11. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Spartan Bioscience today announced that it has ... (MFDS) regulatory approval for its Spartan RX CYP2C19 ... than 60 minutes from a non-invasive cheek swab. , ... doctors to determine therapeutic strategies for drugs metabolized by ... the world’s most commonly prescribed drugs such as Plavix® ...
(Date:11/27/2014)... England , November 27, 2014 ... online on ScienceDirect   Elsevier , ... products and solutions, is pleased to announce the launch ... . The launch of ... the rapid advances at the forefront of applied sciences ...
(Date:11/27/2014)... -- Calcivis, a medical devices company ... today announces that it has completed a first ... System. The Calcivis Caries Activity Imaging ... combination designed to transform the assessment and management ... unique, proprietary bioluminescence approach combined with a specialised ...
(Date:11/27/2014)... Washington, and PITTSFIELD, Massachusetts, USA (PRWEB) November 26, 2014 ... cancer cells with more accuracy, additive systems to enable ... highway safety by analyzing road conditions are among finalists ... for Photonics Innovation . The awards are sponsored by ... , and Photonics Media . , Winners will ...
Breaking Biology Technology:Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Biomarkers - technologies, markets and companies , , ... , , ... This report follows the broad definition of a biomarker as a ...
... GUANGZHOU, China , June 3 /PRNewswire-Asia/ ... Company"), primarily a,manufacturer, leading distributor and developer of Western pharmaceuticals,traditional Chinese ... Meeting of Stockholders (the "Annual,Meeting") held on May 27, 2010 ... ...
... DUBLIN and PHILADELPHIA , June 3, 2010 ... company,announces that its subsidiary Shire LLC has filed a lawsuit in the ... and Anchen, Inc. (collectively "Anchen") for the infringement of U.S.,Patent Nos. 5,854,290 ... , , ...
Cached Biology Technology:Reportlinker Adds Biomarkers - Technologies, Markets and Companies 2Reportlinker Adds Biomarkers - Technologies, Markets and Companies 3Reportlinker Adds Biomarkers - Technologies, Markets and Companies 4Reportlinker Adds Biomarkers - Technologies, Markets and Companies 5Reportlinker Adds Biomarkers - Technologies, Markets and Companies 6Reportlinker Adds Biomarkers - Technologies, Markets and Companies 7Reportlinker Adds Biomarkers - Technologies, Markets and Companies 8Reportlinker Adds Biomarkers - Technologies, Markets and Companies 9Reportlinker Adds Biomarkers - Technologies, Markets and Companies 10Reportlinker Adds Biomarkers - Technologies, Markets and Companies 11Reportlinker Adds Biomarkers - Technologies, Markets and Companies 12Reportlinker Adds Biomarkers - Technologies, Markets and Companies 13Reportlinker Adds Biomarkers - Technologies, Markets and Companies 14Reportlinker Adds Biomarkers - Technologies, Markets and Companies 15Reportlinker Adds Biomarkers - Technologies, Markets and Companies 16Reportlinker Adds Biomarkers - Technologies, Markets and Companies 17Reportlinker Adds Biomarkers - Technologies, Markets and Companies 18Reportlinker Adds Biomarkers - Technologies, Markets and Companies 19Reportlinker Adds Biomarkers - Technologies, Markets and Companies 20Reportlinker Adds Biomarkers - Technologies, Markets and Companies 21Reportlinker Adds Biomarkers - Technologies, Markets and Companies 22Reportlinker Adds Biomarkers - Technologies, Markets and Companies 23Reportlinker Adds Biomarkers - Technologies, Markets and Companies 24Reportlinker Adds Biomarkers - Technologies, Markets and Companies 25China Medicine Announces Results of Annual Meeting of Stockholders 2China Medicine Announces Results of Annual Meeting of Stockholders 3INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc. 2INTUNIV(TM) - Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc. 3
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
(Date:11/18/2014)... , Nov. 17, 2014   ... EMC collaborate to develop The Partners Data Lake, ... The Partners Data Lake will allow researcher and ... diagnostics, treatment and the lives of patients ... and clinical activities across the Partners system, breaking ...
(Date:11/11/2014)... 2014  Forensicon, Inc., a Chicago ... announce the promotion of Yaniv Schiff from ... In Schiff,s new role as Director, he will lead ... forensics examiners and provide leadership within the company,s digital ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon in ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
... release is available in German . ... in micro- and nanotechnologies for users from science and ... is starting operation: Ten leading institutions from research and ... total of 36 high-tech installations along with the corresponding ...
... the U.S. from Europe and other places, garlic mustard first ... indicates that eventually, however, its primary weapon a fungus-killing ... The study, in Proceedings of the National Academy of ... evolutionary forces can alter the very attributes that give an ...
... CORVALLIS, Ore. Research in the Linus Pauling Institute at ... previously have been studied for their ability to prevent cancer, ... treating it working side-by-side with the conventional drugs that ... published in the International Journal of Cancer examined ...
Cached Biology News:Scientific pathways into the nanoworld 2Scientific pathways into the nanoworld 3Over time, an invasive plant loses its toxic edge 2Over time, an invasive plant loses its toxic edge 3Natural compounds, chemotherapeutic drugs may become partners in cancer therapy 2Natural compounds, chemotherapeutic drugs may become partners in cancer therapy 3
... Edition of Molecular Imaging (MI) Software for ... science research and drug discovery applications. The ... Food and Drug Administrations Code of Federal ... Electronic Signatures [21 CFR Part 11]. KODAK ...
... Tissue Arrays are intended for laboratory research ... fixed in neutral buffered formalin and embedded ... was performed by certified pathologists. Tissue ... and relocated into a new recipient paraffin ...
... industry standard microarray image analysis software because ... analysis tools, visualizations, automation capabilities, performance and ... with every GenePix scanner, and it also ... all types of arrays. A wide range ...
... applications not requiring confocal, the BD Pathway ... the Pathway 435. And, the Pathway 415 ... applications require it. High-performance, ... to use the laser autofocus, camera autofocus, ...
Biology Products: